09/16/2024 7:46 PM | Hughes-Wilson Alexandra (Reporting) Mereo BioPharma Group (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/16/2024 7:47 PM | Fox Christine Ann (Reporting) Mereo BioPharma Group (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/16/2024 7:48 PM | Mereo BioPharma Group (Issuer) Sermon Charles (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/16/2024 7:49 PM | Lewicki John A. (Reporting) Mereo BioPharma Group (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/16/2024 7:50 PM | Mereo BioPharma Group (Issuer) Scots-Knight Denise (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2024 3:47 PM | Hughes-Wilson Alexandra (Reporting) Mereo BioPharma Group (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2024 3:49 PM | Mereo BioPharma Group (Issuer) Scots-Knight Denise (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
09/13/2024 3:49 PM | Lewicki John A. (Reporting) Mereo BioPharma Group (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2024 3:50 PM | Fox Christine Ann (Reporting) Mereo BioPharma Group (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2024 3:57 PM | Mereo BioPharma Group (Issuer) Sermon Charles (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2024 3:05 PM | Fox Christine Ann (Reporting) Mereo BioPharma Group (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024 3:05 PM | Mereo BioPharma Group (Subject) Sermon Charles (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024 3:05 PM | Lewicki John A. (Reporting) Mereo BioPharma Group (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024 3:05 PM | Mereo BioPharma Group (Subject) Scots-Knight Denise (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024 3:05 PM | Hughes-Wilson Alexandra (Reporting) Mereo BioPharma Group (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024 5:13 PM | Mereo BioPharma Group (Issuer) PAKIANATHAN DEEPIKA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/22/2024 5:35 PM | Mereo BioPharma Group (Subject) PAKIANATHAN DEEPIKA (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024 7:19 AM | Mereo BioPharma Group (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024 7:09 AM | Mereo BioPharma Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/11/2024 10:46 AM | JANUS HENDERSON GROUP PLC (Filed by) Mereo BioPharma Group (Subject)
| Form SC 13G | |
06/27/2024 3:15 PM | Hughes-Wilson Alexandra (Reporting) Mereo BioPharma Group (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 3:15 PM | Mereo BioPharma Group (Issuer) Scots-Knight Denise (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 3:15 PM | Fox Christine Ann (Reporting) Mereo BioPharma Group (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 3:15 PM | Lewicki John A. (Reporting) Mereo BioPharma Group (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 3:15 PM | Mereo BioPharma Group (Issuer) Sermon Charles (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 5:13 PM | Hughes-Wilson Alexandra (Reporting) Mereo BioPharma Group (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 5:13 PM | Fox Christine Ann (Reporting) Mereo BioPharma Group (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 5:14 PM | Mereo BioPharma Group (Issuer) Sermon Charles (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 5:15 PM | Mereo BioPharma Group (Issuer) Scots-Knight Denise (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 5:21 PM | Lewicki John A. (Reporting) Mereo BioPharma Group (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/24/2024 5:53 PM | Fox Christine Ann (Reporting) Mereo BioPharma Group (Subject)
| Form 144/A | |
06/24/2024 5:58 PM | Mereo BioPharma Group (Subject) Sermon Charles (Reporting)
| Form 144/A | |
06/24/2024 6:00 PM | Hughes-Wilson Alexandra (Reporting) Mereo BioPharma Group (Subject)
| Form 144/A | |
06/24/2024 6:04 PM | Mereo BioPharma Group (Subject) Scots-Knight Denise (Reporting)
| Form 144/A | |
06/24/2024 6:04 PM | Lewicki John A. (Reporting) Mereo BioPharma Group (Subject)
| Form 144/A | |
06/20/2024 3:27 PM | Mereo BioPharma Group (Subject) Scots-Knight Denise (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2024 3:30 PM | Fox Christine Ann (Reporting) Mereo BioPharma Group (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2024 3:32 PM | Mereo BioPharma Group (Subject) Sermon Charles (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2024 3:34 PM | Hughes-Wilson Alexandra (Reporting) Mereo BioPharma Group (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024 4:16 PM | Mereo BioPharma Group (Issuer) Rosen David Efraim (Reporting) Rubric Capital Management LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 3:30 PM | Mereo BioPharma Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
625,000% Gain (Ad) Imagine swapping your daily coffee expense for a future free of financial worries.
It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market.
Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here |
06/11/2024 8:15 PM | Mereo BioPharma Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/27/2024 11:15 PM | Mereo BioPharma Group (Filer)
| Form EFFECT | |
05/23/2024 8:54 PM | Hughes-Wilson Alexandra (Reporting) Mereo BioPharma Group (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 5:38 PM | Hughes-Wilson Alexandra (Reporting) Mereo BioPharma Group (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2024 3:16 PM | Mereo BioPharma Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/15/2024 3:49 PM | Mereo BioPharma Group (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
05/15/2024 3:19 PM | Mereo BioPharma Group (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024 6:36 AM | Mereo BioPharma Group (Filer)
| Form ARS | |
04/24/2024 6:30 AM | Mereo BioPharma Group (Filer)
| Form DEF 14A | |
04/16/2024 1:58 PM | Mereo BioPharma Group (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
04/15/2024 6:30 AM | Mereo BioPharma Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/27/2024 4:20 PM | Mereo BioPharma Group (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2024 5:51 PM | Mereo BioPharma Group (Subject) ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024 1:11 PM | Mereo BioPharma Group (Subject) Rock Springs Capital Management LP (Filed by)
| Form SC 13G/A | |
02/14/2024 11:36 AM | MANGROVE PARTNERS IM, LLC (Filed by) Mereo BioPharma Group (Subject)
| Form SC 13G | |
02/13/2024 4:26 PM | Mereo BioPharma Group (Subject) SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/05/2024 4:09 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) Mereo BioPharma Group (Subject)
| Form SC 13G | |
01/23/2024 3:16 PM | Mereo BioPharma Group (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/08/2024 6:08 AM | Mereo BioPharma Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/02/2024 3:16 PM | Hughes-Wilson Alexandra (Reporting) Mereo BioPharma Group (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:17 PM | Mereo BioPharma Group (Issuer) Shames Daniel (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:18 PM | Mereo BioPharma Group (Issuer) Sermon Charles (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:15 PM | Bender Jeremy (Reporting) Mereo BioPharma Group (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:15 PM | Mereo BioPharma Group (Issuer) Roberts Justin Hunter (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:15 PM | Mereo BioPharma Group (Issuer) Yoskowitz Marc J (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:15 PM | Jacquet Pierre (Reporting) Mereo BioPharma Group (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:15 PM | Mereo BioPharma Group (Issuer) WYZGA MICHAEL S (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:15 PM | Mereo BioPharma Group (Issuer) Scots-Knight Denise (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:15 PM | Lewicki John A. (Reporting) Mereo BioPharma Group (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:15 PM | Jenkins Annalisa (Reporting) Mereo BioPharma Group (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:15 PM | Fox Chrisitne Ann (Reporting) Mereo BioPharma Group (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:16 PM | Mereo BioPharma Group (Issuer) PAKIANATHAN DEEPIKA (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/18/2023 3:16 PM | Mereo BioPharma Group (Filer)
| Form 8-A12B/A | |
11/29/2023 3:15 PM | Mereo BioPharma Group (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/20/2023 7:45 AM | Mereo BioPharma Group (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
11/16/2023 6:01 AM | Mereo BioPharma Group (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/15/2023 6:56 AM | Mereo BioPharma Group (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
11/13/2023 6:31 AM | Mereo BioPharma Group (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
11/08/2023 6:06 AM | Mereo BioPharma Group (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
11/06/2023 6:30 AM | Mereo BioPharma Group (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
11/02/2023 6:30 AM | Mereo BioPharma Group (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |